Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Stroma, Stroma Everywhere (Far More Than You Think).

Olive KP.

Clin Cancer Res. 2015 Aug 1;21(15):3366-8. doi: 10.1158/1078-0432.CCR-15-0416. Epub 2015 May 15.

2.

Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer.

Whatcott CJ, Diep CH, Jiang P, Watanabe A, LoBello J, Sima C, Hostetter G, Shepard HM, Von Hoff DD, Han H.

Clin Cancer Res. 2015 Aug 1;21(15):3561-8. doi: 10.1158/1078-0432.CCR-14-1051. Epub 2015 Feb 18.

3.

Tumoral epithelial and stromal expression of SMAD proteins in pancreatic ductal adenocarcinomas.

Handra-Luca A, Hammel P, Sauvanet A, Ruszniewski P, Couvelard A.

J Hepatobiliary Pancreat Sci. 2013 Mar;20(3):294-302. doi: 10.1007/s00534-012-0518-6.

PMID:
22581056
4.

Microenvironmental factors and extracellular matrix degradation in pancreatic cancer.

Binker MG, Binker-Cosen MJ, Binker-Cosen AA, Cosen-Binker LI.

JOP. 2014 Jul 28;15(4):280-5. doi: 10.6092/1590-8577/2638. Review.

5.

Biomarkers in pancreatic ductal adenocarcinoma.

Gallego J, López C, Pazo-Cid R, López-Ríos F, Carrato A.

Clin Transl Oncol. 2017 Dec;19(12):1430-1437. doi: 10.1007/s12094-017-1691-5. Epub 2017 Jun 14. Review.

PMID:
28616721
6.

Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20).

Wong KM, Horton KJ, Coveler AL, Hingorani SR, Harris WP.

Curr Oncol Rep. 2017 Jul;19(7):47. doi: 10.1007/s11912-017-0608-3. Review.

PMID:
28589527
7.

Pancreatic cancer stroma: controversies and current insights.

Ansari D, Carvajo M, Bauden M, Andersson R.

Scand J Gastroenterol. 2017 Jun - Jul;52(6-7):641-646. doi: 10.1080/00365521.2017.1293726. Epub 2017 Feb 24. Review.

PMID:
28276831
8.

CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions.

Barth PJ, Ebrahimsade S, Hellinger A, Moll R, Ramaswamy A.

Virchows Arch. 2002 Feb;440(2):128-133. doi: 10.1007/s00428-001-0551-3.

PMID:
11964041
9.

Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma.

Diana A, Wang LM, D'Costa Z, Allen P, Azad A, Silva MA, Soonawalla Z, Liu S, McKenna WG, Muschel RJ, Fokas E.

Oncotarget. 2016 Jul 5;7(27):40992-41004. doi: 10.18632/oncotarget.10038.

10.
11.

Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance?

Gebauer F, Kemper M, Sauter G, Prehm P, Schumacher U.

PLoS One. 2017 Jun 5;12(6):e0178703. doi: 10.1371/journal.pone.0178703. eCollection 2017.

12.

Comparison of ILK and ERP29 expressions in benign and malignant pancreatic lesions and their clinicopathological significances in pancreatic ductal adenocarcinomas.

Zhang K, Yao H, Yang Z, Li D, Yang L, Zou Q, Yuan Y, Miao X.

Clin Transl Oncol. 2016 Apr;18(4):352-9. doi: 10.1007/s12094-015-1331-x. Epub 2016 Feb 18.

PMID:
26887611
13.

Matrix control of pancreatic cancer: New insights into fibronectin signaling.

Topalovski M, Brekken RA.

Cancer Lett. 2016 Oct 10;381(1):252-8. doi: 10.1016/j.canlet.2015.12.027. Epub 2015 Dec 29. Review.

14.

The Clinical and Pathological Significance of Nectin-2 and DDX3 Expression in Pancreatic Ductal Adenocarcinomas.

Liang S, Yang Z, Li D, Miao X, Yang L, Zou Q, Yuan Y.

Dis Markers. 2015;2015:379568. doi: 10.1155/2015/379568. Epub 2015 Jul 30.

15.

Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.

Liu C, Yang Z, Li D, Liu Z, Miao X, Yang L, Zou Q, Yuan Y.

Cancer Biomark. 2015;15(6):735-43. doi: 10.3233/CBM-150515.

PMID:
26406402
16.

Combining conventional and stroma-derived tumour markers in pancreatic ductal adenocarcinoma.

Franklin O, Öhlund D, Lundin C, Öman M, Naredi P, Wang W, Sund M.

Cancer Biomark. 2015;15(1):1-10. doi: 10.3233/CBM-140430.

PMID:
25524936
17.

Pathophysiological role of microRNA-29 in pancreatic cancer stroma.

Kwon JJ, Nabinger SC, Vega Z, Sahu SS, Alluri RK, Abdul-Sater Z, Yu Z, Gore J, Nalepa G, Saxena R, Korc M, Kota J.

Sci Rep. 2015 Jun 22;5:11450. doi: 10.1038/srep11450.

18.

Prognostic significance of PINCH signalling in human pancreatic ductal adenocarcinoma.

Scaife CL, Shea J, Emerson L, Boucher K, Firpo MA, Beckerle MC, Mulvihill SJ.

HPB (Oxford). 2010 Jun;12(5):352-8. doi: 10.1111/j.1477-2574.2010.00177.x.

19.

The prognostic significance of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.

Park H, Lee Y, Lee H, Kim JW, Hwang JH, Kim J, Yoon YS, Han HS, Kim H.

Tumour Biol. 2017 Oct;39(10):1010428317718403. doi: 10.1177/1010428317718403.

PMID:
29025374
20.

Prognostic and predictive markers in pancreatic adenocarcinoma.

Le N, Sund M, Vinci A; GEMS collaborating group of Pancreas 2000.

Dig Liver Dis. 2016 Mar;48(3):223-30. doi: 10.1016/j.dld.2015.11.001. Epub 2015 Nov 14. Review.

Supplemental Content

Support Center